"A vaccine candidate for the Bundibugyo strain of Ebola remains undeveloped for human use due to lack of funding. The current outbreak in Central and East Africa has resulted in approximately 200 deaths. CEPI has pledged up to $3.2 million to initiate manufacturing preparations for human trials."